S
SABS
SAB BIOTHERAPEUTICS INC
3.57
-0.22-5.80%After Hours: 3.500 -0.07 -1.96%19:22 02/20 EST
OPEN/PREV CLOSE3.850/3.790
TODAY RANGE3.550-3.850
VOL123.87K
MARKET CAP169.96M
52 WEEK RANGE1.000-6.60
AVG VOL (3M)351.24K
% TURNOVER0.26%
TURNOVER--
P/E (TTM)-1.2726
% RANGE7.92%
EPS(TTM)-2.8053
P/E(FORWARD)14.28
P/B1.027
BVPS3.476
DIVIDEND--
P/S25.07
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP136.55M
SHARES OUTSTANDING47.61M
NEXT EARNINGS03/30-04/03
FREE FLOAT38.25M
LOT SIZE1
EX-DATE01/05/2024
News
Press Releases
Financial Reports
Profile
TipRanks·01/24 11:05
Analysts Predict Up to 400% Spike for These 2 ‘Strong Buy’ Penny Stocks
TipRanks·01/12 22:20
SAB Biotherapeutics Updates SAB-142 Roadmap and Funding Outlook
Dow Jones·01/07 20:39
SAB Biotherapeutics Price Target Announced at $7.00/Share by UBS
TipRanks·01/07 14:00
SAB Biotherapeutics Appoints New Independent Board Chair, Directors
TipRanks·01/07 13:27
SAB Biotherapeutics initiated with a Buy at UBS
TipRanks·01/07 13:21
Aligos Therapeutics initiated with a Buy at UBS
TipRanks·01/07 13:12
SAB Biotherapeutics appoints David Zaccardelli as board chair
Benzinga·01/07 13:04
SAB Biotherapeutics Appoints David Zaccardelli As Board Chair.
Dow Jones·01/07 13:01
*SAB Biotherapeutics Says Rita Jain Joins Board as an Independent Director >SABS
Dow Jones·01/07 13:00
*SAB Biotherapeutics Says David Zaccardelli Joins Its Board as Chair >SABS
Same Industry
Name/Symbol
Change%
Price